Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Virtual reality goggles may cut sedation for IVF patients

NCT ID NCT07190729

Symptom relief Sponsor: Groupe Hospitalier Diaconesses Croix Saint-Simon Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether using a virtual reality mask during egg retrieval for IVF can lower the amount of sedation needed. Fifty-two women received either standard sedation or sedation plus virtual reality distraction. The goal was to see if VR helps patients relax and reduces the need for anesthetic drugs.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Virtual reality via Deepsen™ mask
What this could lead to
If it works, this could offer a way to reduce sedation during egg retrieval, making the procedure more comfortable and speeding up recovery.
What could go wrong
This is a small, completed trial with only 52 participants, so results may not apply to everyone. The effect on sedation needs may be minimal or not clinically significant.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

52 people

The number who actually took part.

Started

Apr 2023

Finished

Sep 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 43 years

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Over 18 and under 43 years of age. * Requiring propofol sedation for oocyte puncture. * Who can be contacted directly by telephone the day after the procedure. * Have given their consent to participate in accordance with the regulations. * Benfeting of a social security scheme or entitled persons (excluding AME). Exclusion Criteria: * Active endometriosis. * Presence of at least one anatomically high ovary which is difficult to puncture. * Inability to understand the information provided. * Under guardianship, curatorship or legal protection. * Under psychiatric care. * Admitted to a health or social establishment for purposes other than this research. * Under constraint or deprived of liberty by judicial or administrative decision. * Impaired communication or neuropsychological disorders. * Ongoing corneal or conjunctival pathologies. * Claustrophobia. * Nausea in the mountains or at sea. * Use of an anxiolytic or sleeping pill in the 12 hours prior to randomisation.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Medically assisted procreation (MAP) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Medically assisted procreation (MAP) Oocyte retrieval

Contacts and locations

Locations

  • Groupe Hospitalier Diaconesses Croix Saint-Simon

    Paris, PARIS, 75020, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.